missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ FES Polyclonal Antibody
Rabbit Polyclonal Antibody
Marca: Invitrogen™ PA528675
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Recommended positive controls: A549, IMR32, HCT116. Predicted reactivity: Mouse (95%), Rat (95%), Bovine (96%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
FES (FPS) is a tyrosine protein kinase that is required for maintenance of cellular transformation. Its chromosomal location is linked to a specific translocation event identified in patients with acute promyelocytic leukemia, and it is also involved in normal hematopoiesis. Alternative splicing results in multiple variants encoding different isoforms.
Especificaciones
| FES | |
| Polyclonal | |
| Unconjugated | |
| FES | |
| AI586313; BB137047; c-fes; EC 2.7.10.2; feline sarcoma (Snyder-Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v-fps) oncogene homolog; feline sarcoma oncogene; feline sarcoma/Fujinami avian sarcoma oncogene homolog; Fes; FES proto-oncogene, tyrosine kinase; FPS; Oncogene FES, feline sarcoma virus; p93c-fes; Proto-oncogene c-Fes; proto-oncogene c-Fps; proto-oncogene tyrosine-protein kinase Fes/Fps; RGD1564385; tyrosine kinase Fps/Fes; tyrosine-protein kinase Fes/Fps; Variant 4 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 2242 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 0.7 mg/mL | |
| 0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7 | |
| P07332 | |
| FES | |
| Recombinant protein encompassing a sequence within the center region of human FES. The exact sequence is proprietary. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido